Ann: Chairman's Address to Shareholders, page-19

Hence my comment re market research. That research has prepared them for commercial negotiations and pricing considerations, they are prepared to go it alone on the US market since there are about 80 - 100 clinicians that anyone would be marketing to, and if someone was to make a hostile takeover, it would become a competitive bidding situation because they are already in discussions with potential suitors.

A bit of news will give the analysts reason to revise their estimates, and it is unlikely to be down.